Magnus Chun, Tahne Vongsavath, Sneh Sonaiya, Lily Liu, Kyaw Min Tun, Kavita Batra, and Robert G. Gish (all Medicine) conducted a to evaluate whether adding somatostatin therapy to standard treatment improves outcomes for non-variceal upper gastrointestinal bleeding (NVUGIB). They found that adjunctive somatostatin offered no clear clinical benefits compared to standard therapy alone. The study highlights the need for better-designed trials to more accurately assess the role of somatostatin in managing NVUGIB.
